SEC FORM 4

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

1. Name and Address of Reporting Person^*

SANQUINI RICHARD L

(Last)

(First)

(Middle)

14087 LOMA RIO DRIVE

(Street)

SARATOGA

95070

(City)

(State)

(Zip)

2. Issuer Name and Ticker or Trading Symbol
SYNAPTICS INC [ SYNA ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director	10% Owner
	Officer (give title below)	Other (specify below)

3. Date of Earliest Transaction (Month/Day/Year)
08/04/2014

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	Code	V	Amount	(A) or (D)	Price		6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
Common Stock	08/04/2014		M		3,516	A	$26.28	25,977	I	By Trust⁽¹⁾
Common Stock	08/04/2014		M		3,000	A	$23.16	28,977	I	By Trust⁽¹⁾
Common Stock	08/04/2014		M		3,375	A	$46.5	32,352	I	By Trust⁽¹⁾
Common Stock	08/04/2014		S		5,200	D	$76.9204⁽²⁾	27,152	I	By Trust⁽¹⁾
Common Stock	08/04/2014		S		3,621	D	$78.1377⁽³⁾	23,531	I	By Trust⁽¹⁾
Common Stock	08/04/2014		S		1,070	D	$78.7331⁽⁴⁾	22,461	I	By Trust⁽¹⁾
Common Stock								9,047	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares	8. Price of Derivative Security (Instr. 5)		10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
Director Stock Option (Right to Buy)	$26.28	08/04/2014		M			3,516	⁽⁵⁾	01/25/2020	Common Stock	3,516	$0.00	0	D
Director Stock Option (Right to Buy)	$23.16	08/04/2014		M			3,000	⁽⁶⁾	10/31/2019	Common Stock	3,000	$0.00	0	D
Director Stock Option (Right to Buy)	$46.5	08/04/2014		M			3,375	⁽⁷⁾	10/28/2020	Common Stock	3,375	$0.00	1,125	D

Explanation of Responses:

1. The shares are held by the Reporting Person as Trustee of the Sanquini 2002 Living Trust, dated January 22, 2002.

2. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $76.48 to $77.27, inclusive. The reporting person undertakes to provide to Synaptics Incorporated (the "Company"), any security holder of the Company, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote to this Form 4.

3. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $77.53 to $78.48, inclusive. The reporting person undertakes to provide to the Company, any security holder of the Company, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote to this Form 4.

4. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $78.61 to $78.82, inclusive. The reporting person undertakes to provide to the Company, any security holder of the Company, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote to this Form 4.

5. 25% of the total number of shares subject to the option vested and became exercisable on the twelve month anniversary of the January 25, 2010 vesting commencement date, and 1/48th of the total number of shares subject to the option vested and became exercisable on the 25th day of each month thereafter until fully vested on January 25, 2014.

6. 1/12th of the total number of shares subject to the option vested and became exercisable on the last day of each month following the October 31, 2012 grant date until fully vested on October 31, 2013.

7. 1/12th of the total number of shares subject to the option vested or shall vest and became or shall become exercisable on the 28th day of each month following the October 28, 2013 grant date until fully vested on October 28, 2014.

Remarks:

	Kermit Nolan, as Attorney-in-Fact	08/06/2014
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.